Increased levels of the oxidative stress marker, nitrotyrosine in patients with provocation test-induced coronary vasospasm

Journal of Cardiology

Volumn 64, Issue 2, 2014, Pages 86-90

  Tanabe, Kan ^a   Kawai, Yasuyuki ^a   Kitayama, Michihiko ^a   Akao, Hironobu ^a   Ishida, Ryoko ^a   Motoyama, Atsushi ^a   Wakasa, Minoru ^a   Saito, Ryuhei ^a   Aoki, Hirofumi ^a   Fujibayashi, Kousuke ^a   Watanabe, Makoto ^a   Tsuchiya, Taketsugu ^a   Kimura, Hiroko ^b   Yoshida, Kenichi ^c   Kajinami, Kouji ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Coronary vasospasm; Endothelial dysfunction; Nitrotyrosine; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; 3-NITROTYROSINE; 4-HYDROXY-2-NONENAL; ACETYLCHOLINE; ALDEHYDE; BIOLOGICAL MARKER; TYROSINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY SPASM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOGENESIS; PROVOCATION TEST; VASOSPASTIC ANGINA PECTORIS; ANALOGS AND DERIVATIVES; BLOOD; CORONARY VASOSPASM; DIAGNOSTIC USE; MYOCARDIAL ISCHEMIA; PHYSIOLOGY;

ACETYLCHOLINE; AGED; ALDEHYDES; BIOLOGICAL MARKERS; CORONARY VASOSPASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; TYROSINE;

EID: 84905590410     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.11.017     Document Type: Article

References (41)

1. Saito H., Itoh T., Itoh M., Kanaya Y., Suzuki T., Hiramori K. Simultaneous multivessel, coronary spasm causing acute myocardial infarction: a case report. Angiology 2007, 58:112-117.
2. Arias M.A., Sánchez A.M., Fajardo A. Sudden cardiac death during Holter recording in a patient with vasospastic angina. Int J Cardiol 2007, 118:e60-e62.
3. Hillis L.D., Braunwald E. Coronary-artery spasm. N Engl J Med 1978, 299:695-702.
4. Yasue H., Kugiyama K. Coronary spasm: clinical features and pathogenesis. Intern Med 1997, 36:760-765.
5. Kawano H., Ogawa H. Endothelial function and coronary spastic angina. Intern Med 2005, 44:91-99.
6. Kugiyama K., Yasue H., Okumura K., Ogawa H., Fujimoto K., Nakao K., Yoshimura M., Motoyama T., Inobe Y., Kawano H. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996, 94:266-271.
7. Kugiyama K., Ohgushi M., Motoyama T., Sugiyama S., Ogawa H., Yoshimura M., Inobe Y., Hirashima O., Kawano H., Soejima H., Yasue H. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997, 30:920-926.
8. Kugiyama K., Motoyama T., Hirashima O., Ohgushi M., Soejima H., Misumi K., Kawano H., Miyao Y., Yoshimura M., Ogawa H., Matsumura T., Sugiyama S., Yasue H. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1998, 32:103-109.
9. Cho S.H., Jeong M.H., Park I.H., Choi J.S., Yoon H.J., Kim K.H., Hong Y.J., Park H.W., Kim K.H., Hong Y.J., Park H.W., Kim J.H., Ahn Y., Cho J.G., Park J.C., et al. Endothelial dysfunction, increased carotid artery intima-media thickness and pulse wave velocity, and increased level of inflammatory markers are associated with variant angina. J Cardiol 2009, 54:183-191.
10. Kawano H., Node K. The role of vascular failure in coronary artery spasm. J Cardiol 2011, 57:2-7.
11. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312:159-163.
12. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-1135.
13. Piper H.M., Garcia-Dorado D., Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998, 38:291-300.
14. Chen C.H., Budas G.R., Churchill E.N., Disatnik M.H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321:1493-1495.
15. Peluffo G., Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007, 75:291-302.
16. Kanayama M., Yamaguchi S., Shibata T., Shibata N., Kobayashi M., Nagai R., Arai H., Takahashi K., Uchida K. Identification of a serum component that regulates cyclooxygenase-2 gene expression in cooperation with 4-hydroxy-2-nonenal. J Biol Chem 2007, 282:24166-24174.
17. Lee S.J., Seo K.W., Yun M.R., Bae S.S., Lee W.S., Hong K.W., Kim C.D. 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways. Free Radic Biol Med 2008, 45:1487-1492.
18. Kozak A.J., Liu F., Funovics P., Jacoby A., Kubant R., Malinski T. Role of peroxynitrite in the process of vascular tone regulation by nitric oxide and prostanoids-a nanotechnological approach. Prostaglandins Leukot Essent Fatty Acids 2005, 72:105-113.
19. DeWitt D.S., Mathew B.P., Chaisson J.M., Prough D.S. Peroxynitrite reduces vasodilatory responses to reduced intravascular pressure, calcitonin gene-related peptide, and cromakalim in isolated middle cerebral arteries. J Cereb Blood Flow Metab 2001, 21:253-261.
20. Elliott S.J., Lacey D.J., Chilian W.M., Brzezinska A.K. Peroxynitrite is a contractile agonist of cerebral artery smooth muscle cells. Am J Physiol 1998, 275:H1585-H1591.
21. Zingarelli B., Day B.J., Crapo J.D., Salzman A.L., Szabó C. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997, 120:259-267.
22. Wattanapitayakul S.K., Weinstein D.M., Holycross B.J., Bauer J.A. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 2000, 14:271-278.
23. Kimura H., Liu S., Yamada S., Uchida K., Matsumoto K., Mukaida M., Yoshida K. Rapid increase in serum lipid peroxide 4-hydroxynonenal (HNE) through monocyte NADPH oxidase in early endotoxemia. Free Radic Res 2005, 39:845-851.
24. Kimura H., Mukaida M., Kuwabara K., Ito T., Hashino K., Uchida K., Matsumoto K., Yoshida K. 4-Hydroxynonenal modifies IgA in rat intestine after lipopolysaccharide injection. Free Radic Biol Med 2006, 41:973-978.
25. Kimura H., Kon H., Furukawa S., Mukaida M., Yamakura F., Matsumoto K., Sone H., Murakami-Murofushi K. Effect of endurance exercise training on oxidative stress in spontaneously hypertensive rats (SHR) after emergence of hypertension. Clin Exp Hypertens 2010, 32:407-415.
26. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
27. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Bames S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994, 269:26066-26075.
28. Chen C.L., Chen J., Rawale S., Varadharaj S., Kaumaya P.P., Zweier J.L., Chen Y.R. Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium. J Biol Chem 2008, 283:27991-28003.
29. Polewicz D., Cadete V.J., Doroszko A., Hunter B.E., Sawicka J., Szczesna-Cordary D., Light P.E., Sawicki G. Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction. J Cell Mol Med 2011, 15:1136-1147.
30. Gielis J.F., Lin J.Y., Wingler K., Van Schil P.E., Schmidt H.H., Moens A.L. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radic Biol Med 2011, 50:765-776.
31. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998, 356:1-11.
32. Mihm M.J., Jing L., Bauer J.A. Nitrotyrosine cause selective vascular endothelial dysfunction and DNA damage. J Cardiovasc Pharmacol 2000, 36:182-187.
33. Kusama Y., Kodani E., Nakagomi A., Otsuka T., Atarashi H., Kishida H., Mizuno K. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. J Nippon Med Sch 2011, 78:4-12.
34. Elfatih A., Anderson N.R., Mansoor S., Ahmed S., Horton R., Holland M.R., Gama R. Plasma nitrotyrosine in reversible myocardial ischaemia. J Clin Pathol 2005, 58:95-96.
35. 2+-induced low density lipoprotein oxidation. FEBS Lett 1996, 398:53-56.
36. Utepbergenov D.I., Mertsch K., Sporbert A., Tenz K., Paul M., Haseloff R.F., Blasig I.E. Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Lett 1998, 424:197-201.
37. Lecture S. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 2006, 355:2003-2011.
38. Lesgards J.F., Frayne I.R., Comte B., Busseuil D., Rhéaume É., Tardif J.C., Rosiers C.D. Differential distribution of 4-hydroxynonenal adducts to sulfur and nitrogen residues in blood proteins as revealed using Raney nickel and gas chromatography-mass spectrometry. Free Radic Biol Med 2009, 47:1375-1385.
39. Liu B., Tewari A.K., Zhang L., Green-Church K.B., Zweier J.L., Chen Y.R., He G. Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim Biophys Acta 2009, 1794:467-485.
40. Fan Q., Yang X.C., Liu Y., Wang L.F., Liu S.H., Ge Y.G., Chen M.L., Wang W., Zhang L.K., Irwin M.G., Xia Z. Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clin Sci (Lond) 2011, 120:251-261.
41. Takarada S., Imanishi T., Goto M., Mochizuki S., Ikejima H., Tsujioka H., Kuroi A., Takeshita T., Akasaka T. First evaluation of real-time nitric oxide changes in the coronary circulation in patients with non-ischemic dilated cardiomyopathy using a catheter-type sensor. Eur Heart J 2010, 31:2862-2870.